Patent · US Active

Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, as TOR kinase inhibitors

US9416134B2 · kind B2 · utility

5Cited by
22References
25Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 15, 2015
Grant dateAug 16, 2016
Priority date—
Expiry dateApr 15, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are formulations, processes, solid forms and methods of use relating to the Compound for formula 1:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.